Breast, Personalis, 01-PS-001

ClinicalTrials.gov ID NCT06230185

A prospective, multicenter, observational study to evaluate the correlation of Molecular Residual Disease (MRD) detection using circulating tumor DNA guided test to pathological complete response (pCR) after neoadjuvant chemotherapy (NAC) in stage I-III triple negative breast cancer (TNBC). Results from this study aim to improve MRD detection and disease outcomes for future patients.

Patient Newsletter 2025 January

HOA Appoints New CEO Jennifer Pichoske

Hematology-Oncology Associates of CNY (HOA) has appointed Jennifer Pichoske, MS, EMBA, AOCNP as Chief Executive Officer effective February 15, 2025. She succeeds Maryann Roefaro, MS, CEO since 2002, who is retiring.

HOA Appoints New CEO as of Feb. 15, 2025

Cancer Q&A with HOA: January is Cervical Cancer Awareness Month

Patient Newsletter 2024 December

Cancer Q&A with HOA: Providing hope to patients with Jennifer Pichoske

Patient Newsletter 2024 November

The Value of Lung Cancer Screenings - Debbie's Story

Lung cancer screenings are indicated for current and former heavy smokers. Learn why this former smoker says her screening saved her life!

View the story on SpectrumLocalNews.com.

Free Lung Cancer Screening

With November as Lung Cancer Awareness Month, Hematology/Oncology Associates of CNY (HOA) and CRA Medical Imaging (CRA) are offering FREE lung cancer screenings on Saturday, Nov. 2, 8 a.m. – 2 p.m. in three locations:

Pages